- Home
- SBFM vs TCRT Comparison
SBFM vs TCRT Comparison
Compare SBFM & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- TCRT
- Stock Information
- Founded
- SBFM 2006
- TCRT 1998
- Country
- SBFM United States
- TCRT United States
- Employees
- SBFM N/A
- TCRT N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- TCRT Health Care
- Exchange
- SBFM Nasdaq
- TCRT Nasdaq
- Market Cap
- SBFM 3.7M
- TCRT 4.0M
- IPO Year
- SBFM N/A
- TCRT N/A
- Fundamental
- Price
- SBFM $3.00
- TCRT $2.21
- Analyst Decision
- SBFM
- TCRT
- Analyst Count
- SBFM 0
- TCRT 0
- Target Price
- SBFM N/A
- TCRT N/A
- AVG Volume (30 Days)
- SBFM 153.8K
- TCRT 25.7K
- Earning Date
- SBFM 11-11-2024
- TCRT 11-12-2024
- Dividend Yield
- SBFM N/A
- TCRT N/A
- EPS Growth
- SBFM N/A
- TCRT N/A
- EPS
- SBFM N/A
- TCRT N/A
- Revenue
- SBFM $30,481,982.00
- TCRT $7,000.00
- Revenue This Year
- SBFM $86.70
- TCRT N/A
- Revenue Next Year
- SBFM $126.76
- TCRT N/A
- P/E Ratio
- SBFM N/A
- TCRT N/A
- Revenue Growth
- SBFM 109.82
- TCRT N/A
- 52 Week Low
- SBFM $2.42
- TCRT $2.07
- 52 Week High
- SBFM $660.00
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- SBFM 46.45
- TCRT 41.06
- Support Level
- SBFM $2.85
- TCRT $2.07
- Resistance Level
- SBFM $3.05
- TCRT $3.30
- Average True Range (ATR)
- SBFM 0.15
- TCRT 0.23
- MACD
- SBFM 0.02
- TCRT -0.06
- Stochastic Oscillator
- SBFM 43.59
- TCRT 11.38
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.